{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T18:45:12Z","timestamp":1778352312434,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Irrational prescription has a lion share for uncontrolled blood pressure. There is no study assessing prescription pattern among hypertensive patients at the study sites. Therefore, the objective of the current study was to evaluate prescription patterns for hypertension and blood pressure (BP) control at randomly selected hospitals of South Gondar Zone.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A hospital based cross sectional study was conducted from December 1, 2020 to February 30, 2021. Hypertensive patients were selected by systematic random sampling proportionally from study hospitals. Structured questionnaires were used to collect socio-demographic chacteristics and adherence. Data abstraction form was used to collect prescription patterns, BP level and other necessary information. The association of prescription patterns and other variables with blood pressure control was determined by using binary logistic regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All recruited 423 patients were included in data analysis. Among prescriptions for hypertension, on average 93.5% were found to be in line with WHO guideline. About 53% of prescriptions for hypertension were monotherapies. Patient level low medication regimen complexity, and monotherapy were associated with blood pressure control (Ajusted Odds Ratio [AOR]\u2009=\u20092.04, [1.07\u20133.91]; AOR\u2009=\u20093.83 [1.42\u201310.35], respectively). Patients with inappropriate drug selection, and non-adherence were less likely to have controlled BP (AOR\u2009=\u20090.47 [0.26\u20130.85]; AOR\u2009=\u20090.52 [0.34\u20130.85], respectively). Moreover, patients who didn\u2019t have health insurance and follow regular aerobic exercise were less likely to have controlled BP (AOR\u2009=\u20090.42 [0.26\u20130.68]; AOR\u2009=\u20090.53 [0.32\u20130.88], respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Diuretics were the most frequently prescribed drug in monotherapy and in combination with calcium channel blockers (CCBs) as dual therapy. On average, more than 90% of prescription was in accordance with WHO guideline and around one-third of participants experienced at least one moderate or major drug-drug interaction. Patient level low medication regimen complexity and monotherapy were positively associated with BP control whereas, non-adherence, inappropriate drug selection, having no health insurance, and didn\u2019t follow regular aerobic exercise were negatively associated with BP control. Clinicians should be adherent to treatment guidelines and focus on modifiable factors to improve BP control.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40360-022-00635-w","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T07:02:56Z","timestamp":1672383776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prescribing pattern of anti-hypertensive medications among hypertensive outpatients at selected hospitals of South Gondar Zone, Amhara, Ethiopia: a hospital based cross sectional study"],"prefix":"10.1186","volume":"23","author":[{"given":"Taklo Simeneh","family":"Yazie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohannes Shumet","family":"Yimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abebe Muche","family":"Belete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Getaye Tessema","family":"Desta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,30]]},"reference":[{"issue":"6","key":"635_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","volume":"134","author":"KT Mills","year":"2016","unstructured":"Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441\u201350.","journal-title":"Circulation"},{"key":"635_CR2","unstructured":"Organization WH. Guideline for the pharmacological treatment of hypertension in adults: web annex A: summary of evidence. World Health Organization; 2021. Available at https:\/\/www.who.int\/publications\/i\/item\/9789240033993."},{"key":"635_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41581-019-0244-2","volume":"1975","author":"KT Mills","year":"2020","unstructured":"Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;1975:1\u201315. https:\/\/doi.org\/10.1038\/s41581-019-0244-2.","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"635_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41569-021-00559-8","volume":"18","author":"B Zhou","year":"2021","unstructured":"Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18(11):785\u2013802. https:\/\/doi.org\/10.1038\/s41569-021-00559-8.","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"635_CR5","doi-asserted-by":"publisher","first-page":"e103169","DOI":"10.1371\/journal.pone.0103169","volume":"9","author":"A Hara","year":"2014","unstructured":"Hara A, Thijs L, Asayama K, Jacobs L, Wang JG, Staessen JA. Randomised double-blind comparison of placebo and active drugs for effects on risks associated with blood pressure variability in the systolic hypertension in europe trial. PLoS One. 2014;9(8):e103169.","journal-title":"PLoS One"},{"issue":"11","key":"635_CR6","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1080\/17512433.2017.1371590","volume":"10","author":"JM Mbui","year":"2017","unstructured":"Mbui JM, Oluka MN, Guantai EM, Sinei KA, Achieng L, Baker A, et al. Prescription patterns and adequacy of blood pressure control among adult hypertensive patients in Kenya; findings and implications. Expert Rev Clin Pharmacol. 2017;10(11):1263\u201371.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"2","key":"635_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/sono.12179","volume":"6","author":"J Maric","year":"2019","unstructured":"Maric J, Childs J, Esterman A. Barriers and facilitators to the implementation of clinical practice guidelines in sonography. Sonography. 2019;6(2):65\u201379.","journal-title":"Sonography"},{"issue":"3","key":"635_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2174\/1574885514666190424155014","volume":"14","author":"A Siddiqua","year":"2019","unstructured":"Siddiqua A, Alshehri A, Alahmari AM, Alshehri RA, Badawy SS. A study of prescription pattern and compliance of anti-hypertensives with the treatment guidelines in Aseer Region; Saudi Arabia. Curr Drug ther. 2019;14(3):261\u20136.","journal-title":"Curr Drug ther"},{"issue":"11","key":"635_CR9","doi-asserted-by":"publisher","first-page":"e0259421","DOI":"10.1371\/journal.pone.0259421","volume":"16","author":"BK Simegn","year":"2021","unstructured":"Simegn BK, Chelkeba L, Alamirew BD. Clinicians\u2019 prescribing pattern, rate of patients\u2019 medication adherence and its determinants among adult hypertensive patients at Jimma University Medical Center: prospective cohort study. PLoS One. 2021;16(11):e0259421.","journal-title":"PLoS One"},{"issue":"1","key":"635_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-020-01414-3","volume":"20","author":"F Amare","year":"2020","unstructured":"Amare F, Hagos B, Sisay M, Molla B. Uncontrolled hypertension in Ethiopia: a systematic review and meta-analysis of institution-based observational studies. BMC Cardiovasc Disord. 2020;20(1):1\u20139.","journal-title":"BMC Cardiovasc Disord"},{"key":"635_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/IPRP.S124047","volume":"6","author":"TM Abegaz","year":"2017","unstructured":"Abegaz TM, Tefera YG, Abebe TB. Antihypertensive drug prescription patterns and their impact on outcome of blood pressure in Ethiopia: a hospital-based cross-sectional study. Integr Pharm Res Pract. 2017;6:29.","journal-title":"Integr Pharm Res Pract"},{"key":"635_CR12","doi-asserted-by":"crossref","unstructured":"Aberhe W, Mariye T, Bahrey D, Zereabruk K, Hailay A, Mebrahtom G. Prevalence and factors associated with uncontrolled hypertension among adult hypertensive patients on follow-up at Northern Ethiopia, 2019: crosssectional study. Pan African Med J. 2020;15;36(187):1\u20134.","DOI":"10.1155\/2020\/8896990"},{"issue":"1","key":"635_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-020-1432-4","volume":"20","author":"K Cardwell","year":"2020","unstructured":"Cardwell K, Kerse N, Hughes CM, Teh R, Moyes SA, Menzies O, Rolleston A, Broad JB, Ryan C. Does potentially inappropriate prescribing predict an increased risk of admission to hospital and mortality? A longitudinal study of the \u2018oldest old.\u2019 BMC Geriatr. 2020;20(1):1\u20139.","journal-title":"BMC Geriatr"},{"issue":"1","key":"635_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.7705\/biomedica.5787","volume":"41","author":"A Fern\u00e1ndez","year":"2021","unstructured":"Fern\u00e1ndez A, G\u00f3mez F, Curcio CL, Pineda E, Souza JF. Prevalence and impact of potentially inappropriate medication on community-dwelling older adults. Biom\u00e9dica. 2021;41(1):111\u201322.","journal-title":"Biom\u00e9dica"},{"issue":"2","key":"635_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.13189\/app.2013.010205","volume":"1","author":"K Sichieri","year":"2013","unstructured":"Sichieri K, Baldacin A, Takahashi J, Secoli S, Cuce M, Martinez M, Fern\u00e1ndez Garrido JJ. Mortality associated with the use of inappropiate drugs according Beers Criteria: a systematic review. Adv Pharmacol Pharm. 2013;1(2):74\u201384.","journal-title":"Adv Pharmacol Pharm"},{"key":"635_CR16","volume-title":"Administration and control authority standard treatment guidelines","author":"FMHACA","year":"2014","unstructured":"FMHACA. Administration and control authority standard treatment guidelines. 3rd ed. 2014. 2014.","edition":"3"},{"issue":"5","key":"635_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507\u201320.","journal-title":"JAMA"},{"key":"635_CR18","unstructured":"Comission P census. Summary and statistical report of the 2007 Population and Housing Census of Ethiopia: Population Size by age and sex. Available at https:\/\/www.ethiopianreview.com\/pdf\/001\/Cen2007_firstdraft%281%29.pdf."},{"issue":"7","key":"635_CR19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1751-7176.2012.00634.x","volume":"14","author":"V Korb-Savoldelli","year":"2012","unstructured":"Korb-Savoldelli V, Gillaizeau F, Pouchot J, Lenain E, Postel\u2010Vinay N, Plouin P, et al. Validation of a french version of the 8\u2010item morisky medication adherence scale in hypertensive adults. J Clin Hypertens. 2012;14(7):429\u201334.","journal-title":"J Clin Hypertens"},{"issue":"11","key":"635_CR20","doi-asserted-by":"publisher","first-page":"e005263","DOI":"10.1161\/CIRCOUTCOMES.118.005263","volume":"11","author":"KL Piercy","year":"2018","unstructured":"Piercy KL, Troiano RP. Physical activity guidelines for Americans from the US department of health and human services: Cardiovascular benefits and recommendations. Cir Cardiovasc Qual Outcomes. 2018;11(11):e005263.","journal-title":"Cir Cardiovasc Qual Outcomes"},{"key":"635_CR21","doi-asserted-by":"crossref","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jones DW, MacLaughlin EJ, Muntner P.\u00a02017.\u00a0ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood Ppressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269\u2013324.","DOI":"10.1161\/HYP.0000000000000066"},{"key":"635_CR22","unstructured":"Micromedex\u00ae HealthCare Series (internet database) Version 2.0. Greenwood Village: Thomson Healthcare Inc. 2013. http:\/\/www.micromedexsolutions.com. Accessed 24 Jan 2021."},{"key":"635_CR23","doi-asserted-by":"crossref","unstructured":"Shimels T, Tadesse S, Melesse Abebaw TT, Bilal AI. Pattern of medication prescribing and factors associated with meeting of target blood pressure among persons with hypertension in Federal Police Referral Hospital,\u00a0Ethiopia. Ann Adv Biomed Sci. 2019;2(1):000124.","DOI":"10.23880\/aabsc-16000124"},{"issue":"12","key":"635_CR24","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1002\/pds.3694","volume":"23","author":"CG Rowan","year":"2014","unstructured":"Rowan CG, Turner JR, Shah A, Spaeder JA. Antihypertensive treatment and blood pressure control relative to hypertension treatment guidelines. Pharmacoepidemiol Drug Saf. 2014;23(12):1294\u2013302.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"635_CR25","first-page":"519","volume":"9","author":"F Shukrala","year":"2015","unstructured":"Shukrala F, Gabriel T. Assessment of prescribing, dispensing, and patient use pattern of antihypertensive drugs for patients attending outpatient department of Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia. Drug Des Devel Ther. 2015;9:519.","journal-title":"Drug Des Devel Ther"},{"key":"635_CR26","doi-asserted-by":"publisher","first-page":"100003","DOI":"10.1016\/j.ijchy.2019.100003","volume":"1","author":"AA Oso","year":"2019","unstructured":"Oso AA, Adefurin A, Benneman MM, Oso OO, Taiwo MA, Adebiyi OO, et al. Health insurance status affects hypertension control in a hospital based internal medicine clinic. Int J Cardiol Hypertens. 2019;1:100003.","journal-title":"Int J Cardiol Hypertens"},{"issue":"11","key":"635_CR27","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00228-017-2315-2","volume":"73","author":"LL Pantuzza","year":"2017","unstructured":"Pantuzza LL, Ceccato M, das GB, Silveira MR, Junqueira LMR, Reis AMM. Association between medication regimen complexity and pharmacotherapy adherence: a systematic review. Eur J Clin Pharmacol. 2017;73(11):1475\u201389.","journal-title":"Eur J Clin Pharmacol"},{"key":"635_CR28","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/MLR.0b013e3181d567bd","volume":"48","author":"A Dragomir","year":"2010","unstructured":"Dragomir A, C\u00f4t\u00e9 R, Roy L, Blais L, Lalonde L, B\u00e9rard A, et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care. 2010;48:418\u201325.","journal-title":"Med Care"},{"key":"635_CR29","doi-asserted-by":"crossref","first-page":"204800401989275","DOI":"10.1177\/2048004019892758","volume":"8","author":"A Getenet","year":"2019","unstructured":"Getenet A, Tesfa M, Ferede A, Molla Y. Determinants of adherence to anti-hypertensive medications among adult hypertensive patients on follow-up in Hawassa Referral Hospital: a case\u2013control study. JRSM Cardiovasc Dis. 2019;8:2048004019892758.","journal-title":"JRSM Cardiovasc Dis"},{"issue":"11","key":"635_CR30","doi-asserted-by":"publisher","first-page":"e6150","DOI":"10.1097\/MD.0000000000006150","volume":"96","author":"H Wen","year":"2017","unstructured":"Wen H, Wang L. Reducing effect of aerobic exercise on blood pressure of essential hypertensive patients: a meta-analysis. Medicine (Baltimore). 2017;96(11):e6150.","journal-title":"Medicine (Baltimore)"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-022-00635-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-022-00635-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-022-00635-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T07:07:33Z","timestamp":1672384053000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-022-00635-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["635"],"URL":"https:\/\/doi.org\/10.1186\/s40360-022-00635-w","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,30]]},"assertion":[{"value":"15 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from Debre Tabor University, College of Health Science, Institutional Ethical Review Committee and informed consent was obtained from all participants. The study was done in line with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}